Clinical Evaluation of the Scopio Cell Morphology Technology

Fondazione Policlinico Universitario Agostino Gemelli IRCCS300 enrolled

Overview

Digital morphology is currently expanding and developing new applications based on artificial intelligence software. We recently published a study comparing screen validation and microscopic reading of bone marrow aspirates. The aim of the current research will be the comparison between optical microscope reading and automatic pre-classification (AI based)

Study Type

OBSERVATIONAL

Enrollment

300

Conditions

Blood Cancer

Interventions

Blood cells classificationDIAGNOSTIC_TEST

Comparison of the classification of peripheral blood and bone marrow cells with optical microscope reading with pre-classification using Scopio technology (AI based)

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients suffering from hemopathies with bone marrow aspirate assessable under the optical microscope Exclusion Criteria: * Patients not affected by blood disorders * Patients suffering from hemopathies with bone marrow aspirate that cannot be assessed under the optical microscope

Locations (1)

Fondazione Policlinico Universitario A. Gemelli IRCCS

Roma, Italy

Outcomes

Primary Outcomes

Optical microscope reading and automatic pre-classification

Comparison between optical microscope reading and automatic pre-classification (AI based)

Time frame: 12 months

Central Contacts

Patrizia Chiusolo, MD

CONTACT

+390630154206 patrizia.chiusolo@unicatt.it

Elena Rossi, MD

CONTACT

+390630154206 elena.rossi@unicatt.it

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.